Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON56637
NL-OMON56637
Not yet recruiting
Phase 4

Microvascular Resistance Reserve Assessment Derived from Absolute flow and Resistance by PET and CT - The MASTER-PACT study

Amsterdam UMC0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscoronary microvascular dysfunctiondysfunction of small arteries of the heart10011082

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
coronary microvascular dysfunction
Sponsor
Amsterdam UMC
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • •1\. Referred for ICA because of suspected CAD
  • •2\. No documented prior history of CAD
  • •3\. Age \>\=18 and \<\=80 years old

Exclusion Criteria

  • •1\. Unstable CAD, Non\-ST\-Elevation Myocardial Infarction (NSTEMI), ST\-Elevation
  • •Myocardial Infarction (STEMI), cardiogenic shock or hemodynamically unstable
  • •patients 2\. Patients with previous coronary artery bypass (CABG) surgery, PCI
  • •or myocardial infarction (MI) 3\. Tortuous or calcified coronary arteries, if
  • •known 4\. Coronary arteries with a small caliber (\<2,5 mm), if known 5\. Atrial
  • •fibrillation, second or third degree atrioventricular block or severe
  • •conduction disturbances with an indication for temporary or permanent pacing 6\.
  • •History of severe COPD or chronic asthma 7\. Renal failure ( i.e. eGFR \< 30
  • •mL/min) 8\. Use of sildenafil (Viagra) or dipyramidol (Persantin) that cannot be
  • •terminated 9\. Contra\-indications for β\-blockers 10\. Allergic reaction to

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
The MASTER-PACT StudyMicrovascular Coronary Artery DiseaseCoronary Artery Disease
NCT06069401Amsterdam UMC, location VUmc40
Completed
Not Applicable
Image derived coronary microvascular resistance and flow reserve in ANOCA
NL-OMON50485Radboud Universitair Medisch Centrum20
Completed
Not Applicable
Application of vascular flow reserve to evaluate ischemic severity of peripheral arterial disease.Peripheral arterial disease
JPRN-UMIN000025228ippon medical school hospital11
Not yet recruiting
Not Applicable
The clinical efficacy of Surgical pleth index (SPI) and analgesia nociception index (ANI)Diseases of the digestive system
KCT0008473Samsung Medical Center47
Not yet recruiting
Phase 4
European microCirculatory Resistance and Absolute Flow Team-The Euro-CRAFT Registry Prospective evaluation of the impact of coronary themodilution on clinical outcomes in chronic coronary syndromeschronic coronary syndromesdisease of the small coronaries10011082
NL-OMON56717CoreAalst BV100